Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.54 USD | -0.57% | -10.91% | +14.84% |
May. 13 | Avalo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 17 | North American Morning Briefing : Stock Futures -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.84% | 10.96M | |
+28.66% | 49.18B | |
+0.96% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.38% | 26.09B | |
-22.60% | 18.71B | |
+8.07% | 13.26B | |
+32.17% | 12.32B | |
-0.37% | 11.99B |
- Stock Market
- Equities
- AVTX Stock
- News Avalo Therapeutics, Inc.
- Earnings Flash (AVTX) AVALO THERAPEUTICS Posts Q1 Revenue $475,000